Hyperglycemia during the immediate period after kidney transplantation

Harini M Chakkera, E. Jennifer Weil, Janna Castro, Raymond L. Heilman, Kunam Sudhakar Reddy, Marek J. Mazur, Khaled Hamawi, David C. Mulligan, Adyr A. Moss, Kristin L. Mekeel, Fernando G Cosio, Curtiss B. Cook

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Background and objectives: Hyperglycemia and new-onset diabetes occurs frequently after kidney transplantation. The stress of surgery and exposure to immunosuppression medications have metabolic effects and can cause or worsen preexisting hyperglycemia. To our knowledge, hyperglycemia in the immediate posttransplantation period has not been studied. Design, setting, participants, & measurements: We conducted a retrospective, observational study to characterize the prevalence and assess the pharmacologic management of hyperglycemia in kidney transplant recipients who underwent transplantation at our center between June 1999 and December 2006. Data were abstracted from electronic and pharmacy databases. Results: The study cohort included 424 patients (mean age 51 yr; 58% men; 25% with pretransplantation diabetes). All patients with and 87% without pretransplantation diabetes had evidence of hyperglycemia (bedside glucose ≥200 mg/dl or physician-instituted insulin therapy), whereas the prevalence of hypoglycemia was low (4.5%). Hyperglycemia was sustained throughout hospitalization. All patients with and 66% without pretransplantation diabetes required insulin at hospital discharge. Patients with pretransplantation diabetes were treated primarily with short-acting insulin during the first 24 h after transplantation but were transitioned to long-acting insulin as the hospital stay progressed. Conclusions: Investigators have historically attempted to identify hyperglycemia after hospital discharge. Our data indicate that a substantial number of patients without pretransplantation diabetes develop hyperglycemia and require insulin during the hospital phase of their care immediately after kidney transplantation. Prospective studies are needed to delineate factors that contribute to development of new-onset diabetes after transplantation among patients with transient hyperglycemia.

Original languageEnglish (US)
Pages (from-to)853-859
Number of pages7
JournalClinical Journal of the American Society of Nephrology
Volume4
Issue number4
DOIs
StatePublished - May 1 2009

Fingerprint

Hyperglycemia
Kidney Transplantation
Transplantation
Insulin
Long-Acting Insulin
Short-Acting Insulin
Hypoglycemia
Immunosuppression
Observational Studies
Length of Stay
Hospitalization
Cohort Studies
Retrospective Studies
Research Personnel
Databases
Prospective Studies
Physicians
Kidney
Glucose

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Epidemiology
  • Critical Care and Intensive Care Medicine
  • Medicine(all)

Cite this

Hyperglycemia during the immediate period after kidney transplantation. / Chakkera, Harini M; Weil, E. Jennifer; Castro, Janna; Heilman, Raymond L.; Reddy, Kunam Sudhakar; Mazur, Marek J.; Hamawi, Khaled; Mulligan, David C.; Moss, Adyr A.; Mekeel, Kristin L.; Cosio, Fernando G; Cook, Curtiss B.

In: Clinical Journal of the American Society of Nephrology, Vol. 4, No. 4, 01.05.2009, p. 853-859.

Research output: Contribution to journalArticle

Chakkera, HM, Weil, EJ, Castro, J, Heilman, RL, Reddy, KS, Mazur, MJ, Hamawi, K, Mulligan, DC, Moss, AA, Mekeel, KL, Cosio, FG & Cook, CB 2009, 'Hyperglycemia during the immediate period after kidney transplantation', Clinical Journal of the American Society of Nephrology, vol. 4, no. 4, pp. 853-859. https://doi.org/10.2215/CJN.05471008
Chakkera, Harini M ; Weil, E. Jennifer ; Castro, Janna ; Heilman, Raymond L. ; Reddy, Kunam Sudhakar ; Mazur, Marek J. ; Hamawi, Khaled ; Mulligan, David C. ; Moss, Adyr A. ; Mekeel, Kristin L. ; Cosio, Fernando G ; Cook, Curtiss B. / Hyperglycemia during the immediate period after kidney transplantation. In: Clinical Journal of the American Society of Nephrology. 2009 ; Vol. 4, No. 4. pp. 853-859.
@article{5bcfc78af1bb4c379c2de531199ff527,
title = "Hyperglycemia during the immediate period after kidney transplantation",
abstract = "Background and objectives: Hyperglycemia and new-onset diabetes occurs frequently after kidney transplantation. The stress of surgery and exposure to immunosuppression medications have metabolic effects and can cause or worsen preexisting hyperglycemia. To our knowledge, hyperglycemia in the immediate posttransplantation period has not been studied. Design, setting, participants, & measurements: We conducted a retrospective, observational study to characterize the prevalence and assess the pharmacologic management of hyperglycemia in kidney transplant recipients who underwent transplantation at our center between June 1999 and December 2006. Data were abstracted from electronic and pharmacy databases. Results: The study cohort included 424 patients (mean age 51 yr; 58{\%} men; 25{\%} with pretransplantation diabetes). All patients with and 87{\%} without pretransplantation diabetes had evidence of hyperglycemia (bedside glucose ≥200 mg/dl or physician-instituted insulin therapy), whereas the prevalence of hypoglycemia was low (4.5{\%}). Hyperglycemia was sustained throughout hospitalization. All patients with and 66{\%} without pretransplantation diabetes required insulin at hospital discharge. Patients with pretransplantation diabetes were treated primarily with short-acting insulin during the first 24 h after transplantation but were transitioned to long-acting insulin as the hospital stay progressed. Conclusions: Investigators have historically attempted to identify hyperglycemia after hospital discharge. Our data indicate that a substantial number of patients without pretransplantation diabetes develop hyperglycemia and require insulin during the hospital phase of their care immediately after kidney transplantation. Prospective studies are needed to delineate factors that contribute to development of new-onset diabetes after transplantation among patients with transient hyperglycemia.",
author = "Chakkera, {Harini M} and Weil, {E. Jennifer} and Janna Castro and Heilman, {Raymond L.} and Reddy, {Kunam Sudhakar} and Mazur, {Marek J.} and Khaled Hamawi and Mulligan, {David C.} and Moss, {Adyr A.} and Mekeel, {Kristin L.} and Cosio, {Fernando G} and Cook, {Curtiss B.}",
year = "2009",
month = "5",
day = "1",
doi = "10.2215/CJN.05471008",
language = "English (US)",
volume = "4",
pages = "853--859",
journal = "Clinical Journal of the American Society of Nephrology",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "4",

}

TY - JOUR

T1 - Hyperglycemia during the immediate period after kidney transplantation

AU - Chakkera, Harini M

AU - Weil, E. Jennifer

AU - Castro, Janna

AU - Heilman, Raymond L.

AU - Reddy, Kunam Sudhakar

AU - Mazur, Marek J.

AU - Hamawi, Khaled

AU - Mulligan, David C.

AU - Moss, Adyr A.

AU - Mekeel, Kristin L.

AU - Cosio, Fernando G

AU - Cook, Curtiss B.

PY - 2009/5/1

Y1 - 2009/5/1

N2 - Background and objectives: Hyperglycemia and new-onset diabetes occurs frequently after kidney transplantation. The stress of surgery and exposure to immunosuppression medications have metabolic effects and can cause or worsen preexisting hyperglycemia. To our knowledge, hyperglycemia in the immediate posttransplantation period has not been studied. Design, setting, participants, & measurements: We conducted a retrospective, observational study to characterize the prevalence and assess the pharmacologic management of hyperglycemia in kidney transplant recipients who underwent transplantation at our center between June 1999 and December 2006. Data were abstracted from electronic and pharmacy databases. Results: The study cohort included 424 patients (mean age 51 yr; 58% men; 25% with pretransplantation diabetes). All patients with and 87% without pretransplantation diabetes had evidence of hyperglycemia (bedside glucose ≥200 mg/dl or physician-instituted insulin therapy), whereas the prevalence of hypoglycemia was low (4.5%). Hyperglycemia was sustained throughout hospitalization. All patients with and 66% without pretransplantation diabetes required insulin at hospital discharge. Patients with pretransplantation diabetes were treated primarily with short-acting insulin during the first 24 h after transplantation but were transitioned to long-acting insulin as the hospital stay progressed. Conclusions: Investigators have historically attempted to identify hyperglycemia after hospital discharge. Our data indicate that a substantial number of patients without pretransplantation diabetes develop hyperglycemia and require insulin during the hospital phase of their care immediately after kidney transplantation. Prospective studies are needed to delineate factors that contribute to development of new-onset diabetes after transplantation among patients with transient hyperglycemia.

AB - Background and objectives: Hyperglycemia and new-onset diabetes occurs frequently after kidney transplantation. The stress of surgery and exposure to immunosuppression medications have metabolic effects and can cause or worsen preexisting hyperglycemia. To our knowledge, hyperglycemia in the immediate posttransplantation period has not been studied. Design, setting, participants, & measurements: We conducted a retrospective, observational study to characterize the prevalence and assess the pharmacologic management of hyperglycemia in kidney transplant recipients who underwent transplantation at our center between June 1999 and December 2006. Data were abstracted from electronic and pharmacy databases. Results: The study cohort included 424 patients (mean age 51 yr; 58% men; 25% with pretransplantation diabetes). All patients with and 87% without pretransplantation diabetes had evidence of hyperglycemia (bedside glucose ≥200 mg/dl or physician-instituted insulin therapy), whereas the prevalence of hypoglycemia was low (4.5%). Hyperglycemia was sustained throughout hospitalization. All patients with and 66% without pretransplantation diabetes required insulin at hospital discharge. Patients with pretransplantation diabetes were treated primarily with short-acting insulin during the first 24 h after transplantation but were transitioned to long-acting insulin as the hospital stay progressed. Conclusions: Investigators have historically attempted to identify hyperglycemia after hospital discharge. Our data indicate that a substantial number of patients without pretransplantation diabetes develop hyperglycemia and require insulin during the hospital phase of their care immediately after kidney transplantation. Prospective studies are needed to delineate factors that contribute to development of new-onset diabetes after transplantation among patients with transient hyperglycemia.

UR - http://www.scopus.com/inward/record.url?scp=66449128494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66449128494&partnerID=8YFLogxK

U2 - 10.2215/CJN.05471008

DO - 10.2215/CJN.05471008

M3 - Article

C2 - 19339426

AN - SCOPUS:66449128494

VL - 4

SP - 853

EP - 859

JO - Clinical Journal of the American Society of Nephrology

JF - Clinical Journal of the American Society of Nephrology

SN - 1555-9041

IS - 4

ER -